Based on the clinical presentation and neuro-imaging findings (lesions in the central corpus callosum), as well as the pronounced dysfunction of the blood–brain barrier (indicated by the highly elevated CSF-to-serum albumin ratio > 47), the differential diagnosis of MS was unlikely. This evidence concerns the gene ALB and myeloid sarcoma.